Intracranial Pressure (ICP) Monitoring Devices: Global Strategic Business Report

Global Intracranial Pressure (ICP) Monitoring Devices Market to Reach $2.2 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Intracranial Pressure (ICP) Monitoring Devices estimated at US$1.4 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at a CAGR of 6.7% over the analysis period 2020-2027. Invasive, one of the segments analyzed in the report, is projected to record 6.5% CAGR and reach US$1.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Non-Invasive segment is readjusted to a revised 8.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $380.2 Million, While China is Forecast to Grow at 9.9% CAGR

The Intracranial Pressure (ICP) Monitoring Devices market in the U.S. is estimated at US$380.2 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$455.4 Million by the year 2027 trailing a CAGR of 10% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.9% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Select Competitors (Total 36 Featured) -

• HaiWeiKang
• HeadSense Medical
• Integra LifeSciences
• Johnson and Johnson
• Medtronic
• Raumedic
• Sophysa Ltd
• Spiegelberg
• Vittamed

What's New for 2022?

• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year